These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anthrax investigation. Science in Ivins case not ironclad, NRC says. Bhattacharjee Y Science; 2011 Feb; 331(6019):835. PubMed ID: 21330501 [No Abstract] [Full Text] [Related]
3. Anthrax investigation. NAS study may fail to settle anthrax case. Bhattacharjee Y Science; 2008 Oct; 322(5898):27. PubMed ID: 18832614 [No Abstract] [Full Text] [Related]
5. Update: Investigation of bioterrorism-related anthrax, 2001. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(45):1008-10. PubMed ID: 11724158 [TBL] [Abstract][Full Text] [Related]
6. Biosecurity. Paul Keim on his life with the FBI during the anthrax investigation. Interview by Yudhijit Bhattacharjee. Keim P Science; 2009 Mar; 323(5920):1416. PubMed ID: 19286527 [No Abstract] [Full Text] [Related]
7. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001. Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664 [TBL] [Abstract][Full Text] [Related]
8. Anthrax investigation. Six anthrax science questions the FBI has yet to answer. Bhattacharjee Y; Enserink M Science; 2008 Aug; 321(5892):1027. PubMed ID: 18719255 [No Abstract] [Full Text] [Related]
9. FBI to reveal anthrax data. Dance A Nature; 2008 Aug; 454(7207):928. PubMed ID: 18754132 [No Abstract] [Full Text] [Related]
10. Prevention of inhalational anthrax in the U.S. outbreak. Brookmeyer R; Blades N Science; 2002 Mar; 295(5561):1861. PubMed ID: 11884746 [No Abstract] [Full Text] [Related]
11. Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):973-6. PubMed ID: 11724150 [TBL] [Abstract][Full Text] [Related]
12. Bioterrorism. Anthrax powder: state of the art? Matsumoto G Science; 2003 Nov; 302(5650):1492-7. PubMed ID: 14645823 [No Abstract] [Full Text] [Related]
13. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):941-8. PubMed ID: 11708591 [TBL] [Abstract][Full Text] [Related]
15. Anthrax. Can lab sleuths clinch the case? Enserink M Science; 2001 Nov; 294(5548):1811. PubMed ID: 11729279 [No Abstract] [Full Text] [Related]
16. Increased US prescription trends associated with the CDC Bacillus anthracis antimicrobial postexposure prophylaxis campaign. Shaffer D; Armstrong G; Higgins K; Honig P; Coyne P; Boxwell D; Beitz J; Leissa B; Murphy D Pharmacoepidemiol Drug Saf; 2003; 12(3):177-82. PubMed ID: 12733470 [TBL] [Abstract][Full Text] [Related]
17. Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001? Mayer TA; Morrison A; Bersoff-Matcha S; Druckenbrod G; Murphy C; Howell J; Hanfling D; Cates R; Pauze D; Earls J Clin Infect Dis; 2003 May; 36(10):1275-83. PubMed ID: 12746773 [TBL] [Abstract][Full Text] [Related]